ghrelin and glp 1 Figure 6 from Ghrelin, CCK, GLP-1, PYY(3-36): Secretory Controls and Physiological Roles in Eating and Glycemia in Health, Obesity, and After RYGB Ghrelin, CCK, GLP-1, and PYY(3–36):
Description
Oxyntomodulin has already shown to reduce food intake and bodyweight in rodents and humans ( In addition to GLP-1R/GCGR dual agonists, a chimeric peptide as dual GLP-1/GIP receptor agonists has been developed, showing enhanced therapeutic potential for obesity and related comorbidities

and Mathijssen, R.H.J., 2016

Contact us today to schedule your free consultation.

This includes provider education, care coordination resources, monitoring systems, and quality improvement initiatives
